Chief Executive Officer
Ben Holmes, Ph.D., is the CEO and Co-Founder of Nanochon. He holds a doctorate in biomedical engineering from The George Washington University, and an undergraduate engineering degree from the University of Virginia. He has extensive experience in tissue engineering and medical device development with both Nanochon and other early stage and commercial medical device companies. Holmes’ leadership at Nanochon’s has successfully gained the company dilutive and non-dilutive funding, as well as numerous awards, advancing their efforts to commercialize innovative cartilage repair technologies.
Chief Technology Officer
Dr. Nathan J. Castro is an experienced biomedical engineer and entrepreneur, specialized in leading the design, testing, regulatory approval and clinical translation of 3D printed medical devices. He has a PhD in Tissue Engineering and Regenerative Medicine from The George Washington University, a MS in Biomedical engineering from The University of Texas at El Paso, and a BA in Chemistry from The University of Texas at El Paso. As CTO and co-founder of Nanochon, Dr. Castro is engaged in early-stage development programs and leading them through all the disciplines of design, regulatory clearance, ISO13485 quality standards and intellectual property portfolio development to arrive at a commercial stage offering.
Chief Financial Officer
Chief of Strategy
Rachel Offenburg, MBA serves as Nanochon’s Chief of Strategy where her day to day is focused on commercial strategy including marketing and communications. She has a Masters in Business Administration from the University of Virginia Darden School of Business, and an undergraduate degree in biology and business management from Emmanuel College. Rachel has extensive background in designing go to market strategies for early stage medical device and biotech startups, developed over the course of her career consulting at IQVIA, leading marketing teams at Bio-Rad Laboratories and managing data analytics platforms at Optum.
Chondrograft™ is not approved yet for marketing.
Sign up with your email address to receive news and updates.
Disclaimer: The images displayed on this website include artistic illustrations and graphical representations which are intended to provide a general sense of the subject matter.